Form 4 for CVS CVS Health
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-16 · accession 0001127602-24-005449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-16 | 2024-02-16 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | S - Sale | $76.95 | -29.5K | 39.8K | -43% | -$2.27M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | S | D | 29,473 | $76.95 | 39,764.76 | D | — | — | (F1) Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between 76.93 to 76.99 per share. |